37 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
16 Sep 20
Other Events
4:07pm
UNINFECTED PNEUMOCYTES VIR-7831 can recruit macrophages and NK cells to kill already infected cells (in vitro effector function assays), NK, natural … PNEUMOCYTES UNINFECTED PNEUMOCYTES VIR-7831 can recruit macrophages and NK cells to kill already infected cells (in vitro effector function assays), while
8-K
EX-99.2
VIR
Vir Biotechnology Inc
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
out of these clinical trials at a higher rate than we anticipate or fail to return for post-treatment follow-up or we may fail to recruit suitable … or impossible to recruit and retain patients in other clinical trials of that same product candidate. Delays or failures in planned patient enrollment
8-K
EX-99.1
VIR
Vir Biotechnology Inc
11 Aug 20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:05pm
. In vitro, VIR-7831 has demonstrated the ability to neutralize SARS-CoV-2, has a high barrier to resistance, an ability to recruit immune cells to kill
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
interests by delivering a significant portion of the new hire package in the form of at-risk equity compensation The critical business need to recruit
10-Q
k5trqj7y1 5uaxpgeni
19 Nov 19
Quarterly report
4:06pm
DRS
batd43g
27 Jun 19
Draft registration statement
12:00am